These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23776619)

  • 1. Targeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imaging.
    Lu RM; Chen MS; Chang DK; Chiu CY; Lin WC; Yan SL; Wang YP; Kuo YS; Yeh CY; Lo A; Wu HC
    PLoS One; 2013; 8(6):e66128. PubMed ID: 23776619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models.
    Chang DK; Li PC; Lu RM; Jane WN; Wu HC
    PLoS One; 2013; 8(12):e83239. PubMed ID: 24386166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
    Gray BP; McGuire MJ; Brown KC
    PLoS One; 2013; 8(8):e72938. PubMed ID: 24009717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.
    Wang T; Hartner WC; Gillespie JW; Praveen KP; Yang S; Mei LA; Petrenko VA; Torchilin VP
    Nanomedicine; 2014 Feb; 10(2):421-30. PubMed ID: 24028893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.
    Dumont N; Merrigan S; Turpin J; Lavoie C; Papavasiliou V; Geretti E; Espelin CW; Luus L; Kamoun WS; Ghasemi O; Sahagian GG; Muller WJ; Hendriks BS; Wickham TJ; Drummond DC
    Nanomedicine; 2019 Apr; 17():71-81. PubMed ID: 30654182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.
    Chang DK; Lin CT; Wu CH; Wu HC
    PLoS One; 2009; 4(1):e4171. PubMed ID: 19137069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
    Lu RM; Chang YL; Chen MS; Wu HC
    Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.
    Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J
    Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.
    Chang DK; Chiu CY; Kuo SY; Lin WC; Lo A; Wang YP; Li PC; Wu HC
    J Biol Chem; 2009 May; 284(19):12905-16. PubMed ID: 19276080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
    Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
    J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide.
    Li C; Wang Y; Zhang X; Deng L; Zhang Y; Chen Z
    Int J Nanomedicine; 2013; 8():1051-62. PubMed ID: 23515368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.